Radiopharmaceutical Isolators: Enhancing Safety and Efficacy in Diagnosis and Treatment

Radiopharmaceuticals are drugs that target specific organs, tissues, or cells in the human body, playing a crucial role in the diagnosis and therapy of diseases. These specialized drugs have proven to be promising treatments in the medical sector. 

The development of radiopharmaceuticals is a complex and lengthy process requiring specialized medical devices for their safe preparation and handling. Among the essential equipment in this field, the Radioactive Pharmaceutical Isolator, or Hot Cell, is vital for conducting efficient and accurate drug development.

Function and Structure of Radiopharmaceutical Isolators

Radiopharmaceutical isolators, similar to containment isolators, use heavy lead shielding around the containment boxes. These boxes are typically made from stainless steel 316L or sometimes from PVC, Plexiglas, Corian, and lead-lined materials. However, due to the presence of radionuclide-emitting radiations, the manufacturing, handling, transporting, and disposing of radiopharmaceuticals is distinct from regular pharmaceuticals.

The interior working area of these isolators is maintained at Class ISO-5 with HEPA-filtered air inlets. The outgoing air is filtered through activated charcoal filters to prevent any airborne radioactivity from escaping the hot cell. The exhaust system of the hot cell is connected to an exhaust vent that is positioned at the highest part of the building where the dispenser is housed.

Key Features of Radiopharmaceutical Isolators

Radiation Protection

Shielding: Hot cells are designed with thick lead or concrete walls that effectively shield operators from radiation. This shielded inlet for radioactive products ensures their safety.

Containment: Isolators provide a sealed environment that prevents the escape of radioactive materials, minimizing exposure to personnel. An additional layer of containment is often used to further protect the surroundings in case of a breach in the primary barrier. This serves as an extraction system to ensure no back contamination.

Controlled Environment

Air Filtration: These systems include HEPA filters and laminar airflow that filter out radioactive particles from the air before it is exhausted from the isolator. This maintains a class A sterile environment, essential for the preparation of radiopharmaceuticals.

Temperature and Humidity Control: These controls ensure the stability and efficacy of the radiopharmaceuticals being handled.

Particle Monitoring System: Equipped with a particle counter sensor within the main chamber and the product introduction pre-chamber.

Automated Systems

Remote Handling: Robotic arms and remote manipulators reduce the need for direct human interaction with radioactive materials, enhancing safety.

Automated Dispensing: Ensures precise dosing and reduces the risk of human error, leading to more accurate and consistent production of radiopharmaceuticals.

Compliance and Quality Assurance

Regulatory Compliance: The hygienic design meets stringent regulatory GMP requirements, ensuring that the radiopharmaceuticals produced are of high quality and safe for operator use. 

Integrated Monitoring Systems: Continuous monitoring of radiation levels detects any increase in radiation promptly, environmental conditions, and operational parameters, and ensures adherence to safety and quality standards. 

Integrity: The materials used in the construction of isolators are resistant to corrosion, chemicals, and radiation, ensuring long-term integrity and safety.

Applications of Radiopharmaceutical Isolators

Radiopharmaceutical Production

Synthesis of Radiopharmaceuticals: The hot cells are used in the production of radiopharmaceuticals for diagnostic imaging (e.g., PET, SPECT, [F-18] FDG, [F-18] NaF, [Ga-68] DOTATATE) and therapeutic applications (e.g., radioimmunotherapy) by diagnosing and monitoring the progression of cancer treatments.

Synthesis of Therapeutics: Hot cells support the production of radiopharmaceuticals used in targeted radiotherapy, such as radioisotopes ([I-131] MIBG, [Lu-177] DOTATATE, and [Lu-177] PSMA) by delivering radiation for targeted radiotherapy to treat specific types of cancer.  

Quality Control: Facilitates the preparation and quality control testing of radiopharmaceuticals, ensuring they meet required standards before patient administration.

Nuclear Medicine Departments

Dose Preparation: In hospital settings, hot cells are used for the preparation and dispensing of patient-specific doses for accurate and safe administration.

Waste Management:  The solid, insulated waste system ensures the safe handling of radioactive waste materials. The capacity to absorb waste during the various stages of the process reduces the risk of contamination.

Research and Development

New Radiopharmaceutical Development: Enables researchers to safely handle radioactive materials while developing new diagnostic and therapeutic agents.

Preclinical Studies: Provides a controlled environment for conducting preclinical studies on the efficacy and safety of new radiopharmaceuticals.

Industrial Applications 

Quality Assurance Testing: Used in industries requiring precise quality assurance testing of products containing radioactive materials.

Radiotracer Production: Essential for the production of radiotracers (pharma isolators) used in various industrial applications, such as non-destructive testing and process optimization.

Integration of mAbs and Radiopharmaceutical Isolators

Monoclonal antibodies (mAbs) and radiopharmaceutical isolators work together in the field of targeted cancer therapies, particularly in radioimmunotherapy. This approach combines the specificity of mAbs with the cell-killing power of radiation.

These isolators are used to safely prepare radioimmunoconjugates, which are complexes formed by attaching a radioactive isotope to a monoclonal antibody. The conjugation process must be handled carefully to ensure the radioactive isotope binds properly to the mAbs without losing its ability to target specific cells.

By leveraging the specificity of mAbs and the potent effects of radiation, this integrated approach enhances the effectiveness of cancer treatment while minimizing damage to healthy tissues.

Safety Consideration for Radiopharmaceutical Isolators

The isolator walls are constructed with lead or other radiation-shielding materials and are typically operated under negative pressure relative to the surrounding environment to prevent the escape of contaminants. Due to the radioactive properties of radiopharmaceuticals, strict safety measures are essential during their handling and usage. Personnel preparing syringes for radiotherapy must be protected from direct radiation exposure emitted by the radioactive isotopes. The preparation, administration, and disposal of these drugs must be carried out by certified personnel who are adequately trained to handle them safely. This includes minimizing exposure time, maximizing distance from the radiation source, and utilizing personal protective equipment (PPE) such as gloves, gowns, and face shields. 

As a pharma isolator manufacturer, Fabtech is dedicated to bringing innovative technologies that shape the healthcare landscape around the world. Radiopharmaceutical isotopes have proven as invaluable tools in therapeutical medicine applications, delivering the highest quality and protection during the pharma production process and drug development.  In line with good manufacturing practices guidelines for pharmaceuticals, these isolators facilitate the development of pharma products in various turnkey pharmaceutical projects.

Serving over 1300 customers and 750 global projects in 62 countries, Fabtech’s strategic and health-centric vision has successfully met the unmet needs of millions of lives. Fill in your details to help us understand your needs.